Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.

Joanna L. Jankowsky, Alena Savonenko, Gabriele Schilling, Jiou Wang, Guilian Xu, David R. Borchelt

Research output: Contribution to journalArticle

Abstract

Neurodegenerative diseases present an extraordinary challenge for medicine due to the grave nature of these illnesses, their prevalence, and their impact on individuals and caregivers. The most common of these age-associated chronic illnesses are Alzheimer's disease (AD) and Parkinson's disease (PD); other examples include the prion disorders, amyotrophic lateral sclerosis (ALS), and the trinucleotide (CAG) repeat diseases. All of these diseases are characterized by well-defined clinical syndromes with progressive courses that reflect the dysfunction and eventual loss of specific neuronal populations. Current therapies provide only symptomatic relief; none significantly alter the course of disease. We describe here how transgenic mice designed to model these diseases have substantially contributed to the identification and validation of many promising new therapies, and conversely how they have quickly and cost effectively eliminated several targets with unrealized expectations.

Original languageEnglish (US)
Pages (from-to)457-464
Number of pages8
JournalCurrent Neurology and Neuroscience Reports
Volume2
Issue number5
StatePublished - Sep 2002

Fingerprint

Neurodegenerative Diseases
Transgenic Mice
Trinucleotide Repeats
Prions
Amyotrophic Lateral Sclerosis
Therapeutics
Caregivers
Parkinson Disease
Alzheimer Disease
Chronic Disease
Medicine
Costs and Cost Analysis
Population

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Transgenic mouse models of neurodegenerative disease : opportunities for therapeutic development. / Jankowsky, Joanna L.; Savonenko, Alena; Schilling, Gabriele; Wang, Jiou; Xu, Guilian; Borchelt, David R.

In: Current Neurology and Neuroscience Reports, Vol. 2, No. 5, 09.2002, p. 457-464.

Research output: Contribution to journalArticle

Jankowsky, Joanna L. ; Savonenko, Alena ; Schilling, Gabriele ; Wang, Jiou ; Xu, Guilian ; Borchelt, David R. / Transgenic mouse models of neurodegenerative disease : opportunities for therapeutic development. In: Current Neurology and Neuroscience Reports. 2002 ; Vol. 2, No. 5. pp. 457-464.
@article{5998c72b39334021bdc57b0e526865be,
title = "Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.",
abstract = "Neurodegenerative diseases present an extraordinary challenge for medicine due to the grave nature of these illnesses, their prevalence, and their impact on individuals and caregivers. The most common of these age-associated chronic illnesses are Alzheimer's disease (AD) and Parkinson's disease (PD); other examples include the prion disorders, amyotrophic lateral sclerosis (ALS), and the trinucleotide (CAG) repeat diseases. All of these diseases are characterized by well-defined clinical syndromes with progressive courses that reflect the dysfunction and eventual loss of specific neuronal populations. Current therapies provide only symptomatic relief; none significantly alter the course of disease. We describe here how transgenic mice designed to model these diseases have substantially contributed to the identification and validation of many promising new therapies, and conversely how they have quickly and cost effectively eliminated several targets with unrealized expectations.",
author = "Jankowsky, {Joanna L.} and Alena Savonenko and Gabriele Schilling and Jiou Wang and Guilian Xu and Borchelt, {David R.}",
year = "2002",
month = "9",
language = "English (US)",
volume = "2",
pages = "457--464",
journal = "Current Neurology and Neuroscience Reports",
issn = "1528-4042",
publisher = "Current Medicine Group",
number = "5",

}

TY - JOUR

T1 - Transgenic mouse models of neurodegenerative disease

T2 - opportunities for therapeutic development.

AU - Jankowsky, Joanna L.

AU - Savonenko, Alena

AU - Schilling, Gabriele

AU - Wang, Jiou

AU - Xu, Guilian

AU - Borchelt, David R.

PY - 2002/9

Y1 - 2002/9

N2 - Neurodegenerative diseases present an extraordinary challenge for medicine due to the grave nature of these illnesses, their prevalence, and their impact on individuals and caregivers. The most common of these age-associated chronic illnesses are Alzheimer's disease (AD) and Parkinson's disease (PD); other examples include the prion disorders, amyotrophic lateral sclerosis (ALS), and the trinucleotide (CAG) repeat diseases. All of these diseases are characterized by well-defined clinical syndromes with progressive courses that reflect the dysfunction and eventual loss of specific neuronal populations. Current therapies provide only symptomatic relief; none significantly alter the course of disease. We describe here how transgenic mice designed to model these diseases have substantially contributed to the identification and validation of many promising new therapies, and conversely how they have quickly and cost effectively eliminated several targets with unrealized expectations.

AB - Neurodegenerative diseases present an extraordinary challenge for medicine due to the grave nature of these illnesses, their prevalence, and their impact on individuals and caregivers. The most common of these age-associated chronic illnesses are Alzheimer's disease (AD) and Parkinson's disease (PD); other examples include the prion disorders, amyotrophic lateral sclerosis (ALS), and the trinucleotide (CAG) repeat diseases. All of these diseases are characterized by well-defined clinical syndromes with progressive courses that reflect the dysfunction and eventual loss of specific neuronal populations. Current therapies provide only symptomatic relief; none significantly alter the course of disease. We describe here how transgenic mice designed to model these diseases have substantially contributed to the identification and validation of many promising new therapies, and conversely how they have quickly and cost effectively eliminated several targets with unrealized expectations.

UR - http://www.scopus.com/inward/record.url?scp=0036727402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036727402&partnerID=8YFLogxK

M3 - Article

C2 - 12169227

AN - SCOPUS:0036727402

VL - 2

SP - 457

EP - 464

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 5

ER -